Close
CDMO Safety Testing 2026
Novotech

Business & Industry

No New Drug Submissions by the FDA With Shutdown in Place

The Food and Drug Administration (FDA), which is already reeling from the layoffs and leadership changes within the Trump Administration, has warned that the government shutdown is also going to delay or pause a significant amount of work at...

Kadans Science Partner secures one of the most significant deals in Glasgow of H1 2025

Chemify scales up operations at Health Innovation Hub Digital chemistry company Chemify is set to embark on the next phase of its business journey with a strategic relocation to Glasgowโ€™s newest purpose-built life science facility, Health Innovation Hub (HiH). Chemify,...

Technology Transfer Models for Emerging Pharmaceutical Hubs

Technology Transfer Models for Emerging Pharmaceutical Regions The global pharmaceutical landscape is experiencing a fundamental transformation as technology transfer models for emerging pharmaceutical regions reshape industry dynamics and create new opportunities for sustainable healthcare solutions. Emerging markets now account for...

U.S. Tariff Relief for EU and Japan on Pharmaceuticals

Donald Trumpโ€™s new tariffs when it comes to pharmaceutical imports are not going to apply to countries having negotiated agreements with the U.S. that contain the provisions on drugs, as per a White House official, therefore delivering promised tariff...

FDA Targets Drugmakers with Letters in a Marketing Crackdown

After the FDA went on to state that it wasย taking on what it has understood to be misleading or deceptive direct-to-consumer pharmaceutical ads, the floodgates have gone on to open, and how? In the first few days post the announcement,...

Trump Order to Go Heavy on D2C Pharmaceutical Ads

US President Donald Trump is all set to order his health department to go ahead and crack down on direct-to-consumer (D2C) pharmaceutical advertising as per a new memorandum that was inked on September 9, 2025. This push, which happens to...

Is US Planning Executive Order on Chinese Pharma Companies?

It is worth noting that the pharmaceutical sectorโ€™s recent source of novel molecules may as well be coming under threat. Apparently, it is the White House which is reportedly preparing an executive order that is going to place restrictions...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป